Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light.

PubWeight™: 1.11‹?› | Rank: Top 10%

🔗 View Article (PMID 1656610)

Published in Vox Sang on January 01, 1991

Authors

B Lambrecht1, H Mohr, J Knüver-Hopf, H Schmitt

Author Affiliations

1: DRK-Blutspendedienst Niedersachsen, Institut Springe, BRD.

Articles citing this

Inactivation of enveloped virus by laser-driven protein aggregation. J Biomed Opt (2012) 0.96

Antimicrobial photodynamic therapy: An overview. J Indian Soc Periodontol (2011) 0.94

Photodynamic inactivation of mammalian viruses and bacteriophages. Viruses (2012) 0.91

Main Properties of the THERAFLEX MB-Plasma System for Pathogen Reduction. Transfus Med Hemother (2011) 0.85

Inactivation of model viruses suspended in fresh frozen plasma using novel methylene blue based device. Iran J Microbiol (2014) 0.79

Secretomes of apoptotic mononuclear cells ameliorate neurological damage in rats with focal ischemia. F1000Res (2014) 0.78

Rationale and mechanism for the low photoinactivation rate of bacteria in plasma. Proc Natl Acad Sci U S A (2013) 0.78

Laser treatment of recurrent herpes labialis: a literature review. Lasers Med Sci (2013) 0.77

Health Technology Assessment of pathogen reduction technologies applied to plasma for clinical use. Blood Transfus (2016) 0.75

Fresh frozen plasma. Viral inactivation may be false reassurance. BMJ (1993) 0.75

A New Proof of Concept in Bacterial Reduction: Antimicrobial Action of Violet-Blue Light (405 nm) in Ex Vivo Stored Plasma. J Blood Transfus (2016) 0.75

Photodynamic treatment of pooled coumarin plasma for external quality assessment of the prothrombin time. J Clin Pathol (2000) 0.75

Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients? Ann Hematol (2017) 0.75

Articles by these authors

Human neoplasms elicit multiple specific immune responses in the autologous host. Proc Natl Acad Sci U S A (1995) 4.89

An Analysis of Phytochrome-mediated Anthocyanin Synthesis. Plant Physiol (1971) 3.19

Centrally mediated decrease in sympathetic tone induced by 2(2,6-dichlorophenylamino)-2 imidazoline (S.T. 155, Catapresan). Eur J Pharmacol (1967) 2.73

Continued breast cancer risk reduction in postmenopausal women treated with raloxifene: 4-year results from the MORE trial. Multiple outcomes of raloxifene evaluation. Breast Cancer Res Treat (2001) 2.26

Evidence for an alpha-sympathomimetic component in the effects of catapresan on vasomotor centres: antagonism by piperoxane. Eur J Pharmacol (1971) 2.15

Phytochrome-mediated repression of enzyme synthesis (lipoxygenase): a threshold phenomenon. Proc Natl Acad Sci U S A (1970) 2.03

Ca2+ triggers massive exocytosis in Chinese hamster ovary cells. EMBO J (1996) 1.80

Phytochrome-mediated induction of enzyme synthesis in mustard seedlings(Sinapis alba L.). Naturwissenschaften (1966) 1.77

Mode of coaction between blue/UV light and light absorbed by phytochrome in light-mediated anthocyanin formation in the milo (Sorghum vulgare Pers.) seedling. Proc Natl Acad Sci U S A (1985) 1.77

Action of -adrenergic blocking drugs on the sympathetic centres and their interactions with the central sympatho-inhibitory effect of clonidine. Arzneimittelforschung (1973) 1.71

A universal spine tester for in vitro experiments with muscle force simulation. Eur Spine J (1994) 1.65

Simultaneous determination of neuromuscular block at the larynx, diaphragm, adductor pollicis, orbicularis oculi and corrugator supercilii muscles. Br J Anaesth (2000) 1.58

Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). II. Central sympathetic structures. Eur J Pharmacol (1968) 1.56

[Pharmacologic study of fenfluramine and its optical isomers]. Arch Int Pharmacodyn Ther (1966) 1.55

Contig assembly of bacterial artificial chromosome clones through multiplexed fluorescence-labeled fingerprinting. Genomics (1999) 1.48

Retroperitoneal lymphangiectasia associated with bilateral renal vein thrombosis. Nephrol Dial Transplant (1997) 1.45

The 'high-irradiance response' in anthocyanin formation as related to the phytochrome level. Photochem Photobiol (1975) 1.38

A technique for recording sympathetic nerve activity in unanaesthetized dogs. Neuropharmacology (1974) 1.38

Low-dose subcutaneous recombinant interleukin-2 in advanced human malignancy: a phase II outpatient study. Mol Biother (1990) 1.37

Gradient formation of anthocyanin in seedlings of Fagopyrum and Sinapis unilaterally exposed to red and far-red light. Photochem Photobiol (1970) 1.36

Health care expenditure in the last months of life. J Health Econ (2000) 1.35

Translation in vitro of rat brain messenger RNA coding for tubulin and actin. Proc Natl Acad Sci U S A (1975) 1.31

Primary reaction of phytochrome. Nature (1971) 1.28

Expression of nuclear genes as affected by treatments acting on the plastids. Planta (1986) 1.27

Sedative effects of alpha-sympathomimetic drugs and their antagonism by adrenergic and cholinergic blocking drugs. Eur J Pharmacol (1971) 1.26

Phytochrome-mediated Induction of Phenylalanine Ammonia-Lyase in Mustard Seedlings: A Contribution to Eliminate Some Misconceptions. Plant Physiol (1972) 1.23

Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole A/Giudicelli JF, Schmitt H, Boissier JR: Studies on dl-4-(2-hydroxy-3-isopropylaminopropoxy)-indole (LB 46), a new potent beta adrenergic blocking drug. J Pharmacol Exp Ther (1969) 1.22

Molecular definition of a novel human galectin which is immunogenic in patients with Hodgkin's disease. J Biol Chem (1997) 1.21

Half-life of phytochrome-induced phenylalanine deaminase in mustard seedlings (Sinapis alba L.). Naturwissenschaften (1966) 1.20

Activation of transcription factor AP-2 mediates UVA radiation- and singlet oxygen-induced expression of the human intercellular adhesion molecule 1 gene. Proc Natl Acad Sci U S A (1996) 1.19

Central cardiovascular effects of morphinomimetic peptides in dogs. Eur J Pharmacol (1977) 1.16

Photooxidative destruction of chloroplasts and its consequences for expression of nuclear genes. Planta (1986) 1.15

[Clinical studies on the effect of a new oral antidiabetic agent Glybenclamide (HB 419)]. Dtsch Med Wochenschr (1969) 1.15

["Off-label" prescribing of drugs in the ambulatory care of children and adolescents]. Dtsch Med Wochenschr (2002) 1.15

The long-term prognosis of the primary glomerulonephritides. A morphological and clinical analysis of 1747 cases. Pathol Res Pract (1992) 1.15

Antinociceptive effects of some alpha-sympathomimetic agents. Neuropharmacology (1974) 1.13

Measurement of spin-transfer observables in p p-->Lambda Lambda at 1.637 GeV/c. Phys Rev Lett (2002) 1.09

Inhibition of angiotensin I-converting enzyme with S 9490: biochemical effects, interspecies differences, and role of sodium diet in hemodynamic effects. J Cardiovasc Pharmacol (1985) 1.08

A twofold action of phytochrome in controlling chlorophyll a accumulation. Photochem Photobiol (1973) 1.06

The consequences of tubulo-interstitial changes for renal function in glomerulopathies. A morphometric and cytological analysis. Pathol Res Pract (1990) 1.06

Reduced frequency of severe hypoglycemia and coma in well-controlled IDDM patients treated with insulin lispro. The Benelux-UK Insulin Lispro Study Group. Diabetes Care (1997) 1.05

Cardiovascular effects of 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (ST 155). I. Peripheral sympathetic system. Eur J Pharmacol (1968) 1.03

A fluorescence-based assay for quantitation of lymphokine-activated killer cell activity. J Immunol Methods (1989) 1.02

Decrease in levels and rates of synthesis of tubulin and actin in developing rat brain. Brain Res (1977) 1.01

Ventrolateral medullary pressor area: site of hypotensive and sympatho-inhibitory effects of (+/-)8-OH-DPAT in anaesthetized dogs. Eur J Pharmacol (1989) 1.01

Analysis of injuries in long-distance triathletes. Int J Sports Med (2003) 1.00

Localization of the hypotenisve effect of 2-(2-6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan). Eur J Pharmacol (1969) 0.99

Involvement of Acetylcholine in Phytochrome-mediated Processes. Plant Physiol (1972) 0.99

A further attempt to characterize sedative receptors activated by clonidine in chickens and mice. Eur J Pharmacol (1973) 0.99

[Actions of diazoxide on the cardiovascular system, on the metabolism of the myocardium and on sympathetic discharges]. Arch Int Pharmacodyn Ther (1968) 0.98

Effect of clonidine on sleep patterns in man. Eur J Clin Pharmacol (1977) 0.98

Pharmacological properties of (N-dicyclopropylmethyl) amino-2-oxazoline (S 3341), an alpha-2 adrenoceptor agonist. J Pharmacol (1986) 0.97

Centrally mediated bradycardia and hypotension induced by narcotic analgesics: dextromoramide and fentanyl. Eur J Pharmacol (1974) 0.97

Toxic epidermal necrolysis in patients receiving glucocorticosteroids. Acta Derm Venereol (1991) 0.97

International validation of a health-related quality of life questionnaire in patients with erosive gastro-oesophageal reflux disease. Aliment Pharmacol Ther (2008) 0.96

Simultaneous induction of glycolate oxidase and glyoxylate reductase in white mustard seedlings by phytochrome. Naturwissenschaften (1970) 0.95

Long-lasting hyperventilation induced by almitrine: evidence for a specific effect on carotid and thoracic chemoreceptors. Eur J Pharmacol (1980) 0.95

Adenosine 5'-triphosphate content and energy charge during photomorphogenesis of the mustard seedling Sinapis alba L. Photochem Photobiol (1976) 0.94

Pharmacological evidence for a central alpha-sympathomimetic mechanism controlling blood pressure and heart rate. Circ Res (1976) 0.94

Action of light, nitrate and ammonium on the levels of NADH- and ferredoxin-dependent glutamate synthases in the cotyledons of mustard seedlings. Planta (1988) 0.94

Unsatisfactory specificities and sensitivities of six enzyme immunoassays for antibodies to hepatitis B core antigen. J Clin Microbiol (1989) 0.94

Pre- and postsynaptic a-adrenoceptor blockade by (imidazolinyl-2)-2-benzodioxane 1-4 (170 150): antagonistic action on the central effects of clonidine. Arch Int Pharmacodyn Ther (1981) 0.93

Sports injuries: population based representative data on incidence, diagnosis, sequelae, and high risk groups. Br J Sports Med (2006) 0.93

Photoinduction of phenylalanine ammonia-lyase in mustard seedlings: involvement of phytochrome. Naturwissenschaften (1968) 0.93

Indication for central vagal endorphinergic control of heart rate in dogs. Eur J Pharmacol (1981) 0.92

Control by phytochrome of the level of nicotinamide nucleotides in the cotyledons of the mustard seedling. Z Naturforsch C (1974) 0.92

The role of autoimmunity in hepatitis C infection. J Hepatol (1995) 0.91

Renal artery stenosis: evaluation with colour duplex ultrasonography. Nephrol Dial Transplant (1997) 0.91

Target structures for HIV-1 inactivation by methylene blue and light. J Med Virol (1995) 0.91

Cyclic 3'5'-adenosine monophosphate and central circulatory control in cats and dogs. Clin Exp Pharmacol Physiol (1977) 0.90

Interactions between the autonomic nervous system and the cardiovascular effects of ouabain in guinea-pigs. Eur J Pharmacol (1982) 0.90

Interactions between 2-(2,6-dichlorophenylamino)-2-imidazoline hydrochloride (St 155, Catapresan) and alpha-adrenergic blocking drugs. Eur J Pharmacol (1970) 0.90

Stimulation of the Shibata shift by phytochrome in the cotyledons of the mustard seedling Sinapis alba L. Photochem Photobiol (1976) 0.89

[Prevalence and correlates of osteoarthritis in Germany. Representative data from the First National Health Survey]. Orthopade (2005) 0.89

An attempt to localize the threshold reaction in phytochrome-mediated control of lipoxygenase synthesis in the mustard seedling. Photochem Photobiol (1976) 0.89

Pharmacokinetics of gentamicin after i.v. infusion or iv bolus. J Antimicrob Chemother (1987) 0.89

Specific affinity labelling of tubulin with bromocolchicine. J Mol Biol (1976) 0.89

New evidence for an -andrenergic component in the sympathetic centres: centrally mediated decrease in sympathetic tone by L-dopa and its antagonism by piperoxane and yohimbine. Eur J Pharmacol (1972) 0.88

Image registration and analysis for quantitative myocardial perfusion: application to dynamic circular cardiac CT. Phys Med Biol (2011) 0.88

Hypothermic effect of alpha-sympathomimetic agents and their antagonism by adrenergic and cholinergic blocking drugs. Neuropharmacology (1972) 0.88

Immuno-isolation of highly purified peroxisomes using magnetic beads and continuous immunomagnetic sorting. Electrophoresis (1998) 0.88

The appearance of competence for phytochrome-mediated anthocyanin synthesis in the cotyledons of Sinapis alba L. Planta (1976) 0.88

Scale up cultivation of primary human umbilical vein endothelial cells on microcarriers from spinner vessels to bioreactor fermentation. Cytotechnology (1996) 0.87

Human trefoil peptides: genomic structure in 21q22.3 and coordinated expression. Eur J Hum Genet (1996) 0.87

Central and peripheral effects of 2-(2,6-dimethylphenylamino)-4-H-5,6-dihydro-1,3-thiazin (Bayer 1470) on the sympathetic system. Eur J Pharmacol (1970) 0.86

Incidence and course of icteric and anicteric transfusion hepatitis. Ger Med Mon (1966) 0.86

Percutaneous renal biopsy: comparison of manual and automated puncture techniques with native and transplanted kidneys. Nephrol Dial Transplant (1994) 0.86

Quipazine-induced hypertension in anaesthetized cats is mediated by central and peripheral 5-HT2 receptors: role of the ventrolateral pressor area. Eur J Pharmacol (1991) 0.86

A cell strain system for small homogeneous strain applications. Biomed Tech (Berl) (1997) 0.86

Characterization of a 72 S mitochondrial ribosome from Saccharomyces cerevisiae. Eur J Biochem (1970) 0.86

New mechanism of antiarrhythmic drug action: increasing L-type calcium current prevents reentrant ventricular tachycardia in the infarcted canine heart. Circulation (2000) 0.86

Dopamine receptors in the femoral vascular bed of the dog as mediators of a vasodilator and sympathoinhibitory effect. Eur J Pharmacol (1977) 0.86